The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Full Text
NEJM -- Avorn J. Paying for Drug Approvals -- Who’s Using Whom? N Engl J Med 2007;356(17):1697-700. DOI: 10.1056/NEJMp078041. Supplementary Audio

Interview with Jerry Avorn and Mark McClellan on the Prescription Drug User Fee Act and its effects on drug safety.

photo of Jerry Avorn
Jerry Avorn

photo of Mark McClellan
Mark McClellan

Supplement to: Avorn J. Paying for Drug Approvals — Who’s Using Whom? N Engl J Med 2007;356(17):1697-700. DOI: 10.1056/NEJMp078041.

Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmaeconomics at Brigham and Women’s Hospital in Boston.

Mark McClellan is a visiting senior fellow at the AEI–Brookings Joint Center for Regulatory Studies, Washington, DC, and is on leave as an associate professor of economics and medicine at Stanford University, Stanford, CA. Dr. McClellan was commissioner of the FDA from November 2002 to March 2004.

Rachel Gotbaum, the interviewer, is an independent producer based in Boston.


 

This Article
-Full Text


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.